Medical Filtration Companies

Medical Filtration Companies - Merck KGaA (Germany) and Sartorius AG (Germany) are Leading Players in the Medical Filtration Market

The medical filtration market is expected to grow at a CAGR of 6.8% to reach USD 9.35 billion by 2030 from USD 6.29 billion in 2024. The factors like stringent regulatory and quality standards and growing focus on infection control are significantly driving the market growth.

Medical Filtration Companies

The key global players in the medical filtration market, such include Merck KGaA (Germany), 3M (Solventum) (US), Danaher (US), Sartorius AG (US), Veolia (France), Thermo Fisher Scientific Inc (US), Donaldson Company Inc (US), Baxter (US), Parker Hannifin Corp (US), Entegris (US), Asahi Kasei Corporation (Japan), and Mann+Hummel (Germany) have a strong foothold in their respective regions and are exploring geographic diversification options to expand their businesses. They are focusing on increasing their market shares through new product launches, mergers and expansions.

To know about the assumptions considered for the study download the pdf brochure

Merck KGaA

Merck KGaA is one of the leading global science and technology company. The company carries out its operation through three major business segments namely, life science, healthcare and electronics. The company offers medical filtration products through its life science business segment catering to various medical applications and end use industries such as hospitals, research institutes and diagnostic centers. The company has recently made and investment of over USD 309 million in its new Life Science Research Center in Germany. This will enhance its process of developing innovative filtration solutions, further enhancing its product portfolio. The company operates globally in 66 countries, with support from major R&D centers in Darmstadt, Boston, Tokyo, and Beijing. This wide reach allows the company to effectively serve a diverse range of markets on every continent, namely Europe, Africa, Asia, Oceania, and the Americas.

Sartorius AG

Sartorius AG is a leading international partner of life science research and the biopharmaceutical industry, specializing in providing innovative solutions in bioprocessing, laboratory technologies, and medical filtration. The company operates through two major business segments namely, bioprocess solutions and lab products & services. The company provides medical filters through both its primary segments. The bioprocess solutions business segment offers an extensive range of products designed for process development and the commercial manufacturing of medical filters. In contrast, this business segment lab products and services, caters to biotech research laboratories and academic research institutes by delivering specialized solutions to support the research and development efforts.

Danaher

Danaher is the world's science and technology leader, operating in three business segments, namely Biotechnology, Life Sciences, and Diagnostics. The company has medical filtration products through its industrial filtration division under the life sciences segment and through the discovery and medical division under the biotechnology segment. The company made a strategic decision of acquiring GE's Biopharma business in March 2020 and rebranded it as Cytiva. This acquisition significantly enhanced its portfolio of bioprocess filtration products. The company has a significant geographic presence along with manufacturing and distribution facilities across North America, Europe, Asia, South America, and Australia, with 24 operating companies globally.

3M (Solventum)

3M produces a wide range of industrial, safety, and consumer products. It conducts business through four core business segments named, Safety & Industrial, Transportation & Electronics, Health Care, and Consumer. The firm provides filtration medical products under the Health Care segment under separation & purification subcategory.  3M has split its healthcare wing into an independent company named Solventum to enhance its operational efficiency and expand its presence in specialized sectors. Effective April 1, 2024, Solventum has decided strategically to focus on medical devices and filtration solutions for the underdeveloped markets.

Related Reports:

Medical Filtration Market by Material (Polyethersulfone; Polyvinylidenefluoride), Applications (Dialysis; Sterile Processing), Process Technology (Ultrafiltration; Microfiltration), Design/Process, End-Users & Region - Global Forecast to 2030

Medical Filtration Market Size,  Share & Growth Report
Report Code
CH 9289
RI Published ON
2/11/2025
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2025 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status